Loading...
OTCM
APPB
Market cap2kUSD
Oct 05, Last price  
0.00USD
IPO
-100.00%
Name

Applied Biosciences Corp

Chart & performance

D1W1MN
OTCM:APPB chart
P/E
—
P/S
0.02
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
142.16%
Revenues
89k
-87.74%
00045,554197,554707,062723,35188,665
Net income
-767k
L-83.58%
-1,822-16,669-28,445-517,656-2,376,101-2,629,327-4,673,557-767,220
CFO
-750k
L-39.67%
-1,822-14,600-30,251-150,835-673,467-905,051-1,242,646-749,714

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.

Key people

Scott Stevens
Chairman of the Board · since 2019
John Southard
Treasurer, Secretary · since 2018
Michael Beaubaire
Director · since 2019
Chris Bridges
President, Director · since 2017
IPO date
Nov 04, 2015
Employees
25
Domiciled in
US
Incorporated in
US
Headquarters & legal address
C/O State Agent And Transfer Syndicate, Inc.
112 North Curry Street
Carson City, NV 89703-4934
US
Previous name
Stony Hill Corp.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT